Pages that link to "Q34373997"
Jump to navigation
Jump to search
The following pages link to Low free testosterone is an independent risk factor for Alzheimer's disease. (Q34373997):
Displaying 50 items.
- A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E epsilon4 allele (Q21261427) (← links)
- Androgens, Aging, and Alzheimer's Disease (Q22306052) (← links)
- The benefits and risks of testosterone replacement therapy: a review (Q24658011) (← links)
- A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis (Q26781496) (← links)
- The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease (Q26799258) (← links)
- Hypothalamic-pituitary-gonadal axis involvement in learning and memory and Alzheimer's disease: more than "just" estrogen (Q27027598) (← links)
- Luteinizing hormone receptor mediates neuronal pregnenolone production via up-regulation of steroidogenic acute regulatory protein expression (Q28568570) (← links)
- Interaction of APOE genotype and testosterone on episodic memory in middle-aged men. (Q30575703) (← links)
- Androgen receptor gene and sex-specific Alzheimer's disease (Q33576938) (← links)
- Estrogen: a master regulator of bioenergetic systems in the brain and body (Q33623924) (← links)
- Down-regulation of serum gonadotropins is as effective as estrogen replacement at improving menopause-associated cognitive deficits (Q33915170) (← links)
- Sex hormone binding globulin and incident Alzheimer's disease in elderly men and women (Q33939101) (← links)
- Elevated mRNA-levels of gonadotropin-releasing hormone and its receptor in plaque-bearing Alzheimer's disease transgenic mice (Q33999164) (← links)
- Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease (Q34091893) (← links)
- Androgen Deprivation Therapy and Future Alzheimer's Disease Risk (Q34504328) (← links)
- Endocrine disruptors as a threat to neurological function (Q34959106) (← links)
- Handgrip strength and cognitive decline in older Mexican Americans (Q35128532) (← links)
- Genetic influences on hippocampal volume differ as a function of testosterone level in middle-aged men (Q35592722) (← links)
- The impact of luteinizing hormone and testosterone on beta amyloid (Aβ) accumulation: Animal and human clinical studies. (Q35677668) (← links)
- Brain and cognition abnormalities in long-term anabolic-androgenic steroid users. (Q35690343) (← links)
- Variants in CYP17 and CYP19 cytochrome P450 genes are associated with onset of Alzheimer's disease in women with down syndrome (Q35748499) (← links)
- Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy (Q35852422) (← links)
- Dysregulation of the hypothalamic-pituitary-gonadal axis with menopause and andropause promotes neurodegenerative senescence (Q36063538) (← links)
- Evaluation of the effects of testosterone and luteinizing hormone on regulation of β-amyloid in male 3xTg-AD mice (Q36102891) (← links)
- Can endocrine disruptors influence neuroplasticity in the aging brain? (Q36130681) (← links)
- Prognostic factors in paediatric anaplastic large cell lymphoma: role of ALK. (Q36436653) (← links)
- The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms. (Q36511930) (← links)
- Luteinizing hormone: Evidence for direct action in the CNS (Q36543895) (← links)
- Androgen cell signaling pathways involved in neuroprotective actions. (Q36713951) (← links)
- Effects of epsilon4 on object recognition in the non-demented elderly (Q36847461) (← links)
- Human chorionic gonadotropin (a luteinizing hormone homologue) decreases spatial memory and increases brain amyloid-beta levels in female rats. (Q37036997) (← links)
- Androgens and male aging: Current evidence of safety and efficacy (Q37084126) (← links)
- Is TNF a link between aging-related reproductive endocrine dyscrasia and Alzheimer's disease? (Q37120749) (← links)
- Genetic and environmental influences of daily and intra-individual variation in testosterone levels in middle-aged men (Q37179119) (← links)
- Sex hormone binding globulin and verbal memory in older men. (Q37203370) (← links)
- Effects of dihydrotestosterone on synaptic plasticity of the hippocampus in mild cognitive impairment male SAMP8 mice. (Q37204144) (← links)
- What are critical outcome measures for patients receiving pituitary replacement following brain injury? (Q37205120) (← links)
- Testosterone replacement attenuates cognitive decline in testosterone-deprived lean rats, but not in obese rats, by mitigating brain oxidative stress. (Q37219312) (← links)
- The worldwide challenge of the dementias: a role for B vitamins and homocysteine? (Q37246161) (← links)
- Are declining testosterone levels a major risk factor for ill-health in aging men? (Q37335851) (← links)
- Pharmacologic approaches to the aging athlete (Q37417117) (← links)
- Androgen deficiency in aging and metabolically challenged men. (Q37961162) (← links)
- Road to Alzheimer's disease: the pathomechanism underlying (Q37972068) (← links)
- Neuroendocrinology-based therapy for Alzheimer's disease (Q37995980) (← links)
- Testosterone deficiency, insulin-resistant obesity and cognitive function (Q38363704) (← links)
- Diet, nutrients and metabolism: cogs in the wheel driving Alzheimer's disease pathology? (Q38413096) (← links)
- Sarcopenia as a Predictor of Future Cognitive Impairment in Older Adults. (Q38415232) (← links)
- Prognostic value of handgrip strength in people aged 60 years and older: A systematic review and meta-analysis (Q38504499) (← links)
- Luteinizing hormone as a key player in the cognitive decline of Alzheimer's disease (Q38510860) (← links)
- Risk of Alzheimer's Disease Among Senior Medicare Beneficiaries Treated With Androgen Deprivation Therapy for Prostate Cancer (Q38608309) (← links)